MCM
NEO icon

McKinley Capital Management’s NeoGenomics NEO Stock Holding History

McKinley Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-183,610
Closed -$2.89M – 146
2024
Q1 		$2.89M Hold
183,610
– – 0.35% 85
2023
Q4 		$2.97M Buy
183,610
+45,260
+33% +$741K 0.38% 79
2023
Q3 		$1.7M Hold
138,350
– – 0.24% 103
2023
Q2 		$2.22M Sell
138,350
-18,100
-12% -$298K 0.3% 97
2023
Q1 		$2.72M Buy
+156,450
New +$2.23M 0.36% 87

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

McKinley Capital Management's NEO Position: Q2 2024 in Review

McKinley Capital Management sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 183,610 shares — an estimated $2.89M sold.

McKinley Capital Management first reported a position in NEO in Q1 2023 and held it in 5 quarters. The position peaked at $2.97M in Q4 2023. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • McKinley Capital Management reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • McKinley Capital Management sold 183,610 NeoGenomics shares in Q2 2024, an estimated $2.89M.
  • McKinley Capital Management first reported a position in NeoGenomics in Q1 2023 and held it in 5 quarters.
  • McKinley Capital Management's NeoGenomics position peaked at $2.97M in Q4 2023.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.